Ser Educacional S.A. (BVMF:SEER3)
| Market Cap | 1.72B +156.1% |
| Revenue (ttm) | 2.22B +11.9% |
| Net Income | 214.44M |
| EPS | 1.68 |
| Shares Out | 127.61M |
| PE Ratio | 8.02 |
| Forward PE | 6.28 |
| Dividend | 0.48 (3.56%) |
| Ex-Dividend Date | Apr 7, 2026 |
| Volume | 311,200 |
| Average Volume | 898,665 |
| Open | 12.60 |
| Previous Close | 12.66 |
| Day's Range | 12.22 - 12.62 |
| 52-Week Range | 6.60 - 14.14 |
| Beta | 0.30 |
| RSI | 51.32 |
| Earnings Date | May 13, 2026 |
About Ser Educacional
Ser Educacional S.A., together with its subsidiaries, operates on-campus and distance-learning undergraduate, graduate, and professional training courses and other education-related areas in Brazil. It offers undergraduate, post graduate, on-campus and digital learning, and vocational courses. The company operates under the UNINASSAU – Centro Universitário Maurício de Nassau, UNINABUCO – Centro Universitário Nabuco, UNG – Universidade Guarulhos, UNAMA – University of the Amazon, UNIVERITAS – Universus Veritas University Center, UNINORTE - North... [Read more]
Financial Performance
Financial StatementsNews
Q4 2025 Ser Educacional SA Earnings Call (English, Portuguese) Transcript
Q4 2025 Ser Educacional SA Earnings Call (English, Portuguese) Transcript
Ser Educacional Earnings Call Transcript: Q4 2025
Double-digit growth in hybrid education and a 22% rise in Adjusted EBITDA marked a strong year, with net income swinging to BRL 74.6 million and leverage at historic lows. Dividend payments resumed, and asset-light expansion continues, focusing on healthcare and in-person programs.
Ser Educacional SA (BSP:SEER3) Q3 2025 Earnings Call Highlights: Strong Cash Generation and ...
Ser Educacional SA (BSP:SEER3) Q3 2025 Earnings Call Highlights: Strong Cash Generation and Student Growth Amidst Market Challenges
Q3 2025 Ser Educacional SA Earnings Call (English, Portuguese) Transcript
Q3 2025 Ser Educacional SA Earnings Call (English, Portuguese) Transcript
Ser Educacional Earnings Call Transcript: Q3 2025
Q3 2025 saw robust financial and operational gains, with cash generation more than doubling year-over-year and leverage dropping over 20%. Student base and average ticket grew, especially in healthcare, while cost controls and efficiency measures drove margin and cash flow improvements.
Q2 2025 Ser Educacional SA Earnings Call (English, Portuguese) Transcript
Q2 2025 Ser Educacional SA Earnings Call (English, Portuguese) Transcript
Q1 2025 Ser Educacional SA Earnings Call (English, Portuguese) Transcript
Q1 2025 Ser Educacional SA Earnings Call (English, Portuguese) Transcript
Ser Educacional Earnings Call Transcript: Q2 2025
Q2 2025 saw double-digit enrollment growth, strong EBITDA and net margin expansion, and a 26% higher net profit versus 2024. Medical programs and hybrid education drove results, while debt and leverage were significantly reduced.
Ser Educacional Earnings Call Transcript: Q1 2025
Strong year-over-year growth in student intake and revenue, with record Adjusted EBITDA and cash generation. Operational leverage, cost control, and expansion in health and medical courses drove margin improvements, while financial leverage neared target levels.
Ser Educacional SA (BSP:SEER3) Q4 2024 Earnings Call Highlights: Strong Cash Generation and ...
Ser Educacional SA (BSP:SEER3) Q4 2024 Earnings Call Highlights: Strong Cash Generation and Enrollment Growth
Ser Educacional Earnings Call Transcript: Q4 2024
Double-digit adjusted EBITDA growth and over 200% increase in net operating cash enabled a 9% net debt reduction and dividend resumption. Health and medical courses drove student base and margin expansion, while operational optimization improved cash flow and leverage.
Ser Educacional Earnings Call Transcript: Q3 2024
Operational optimization drove revenue and margin growth, with adjusted net income turning positive and leverage falling below 1.8x. Enrollment and average ticket rose, especially in health courses, while new medical seats and the Ser Solidarity Program set the stage for future growth.
Ser Educacional Earnings Call Transcript: Q2 2024
Strong student intake and operational synergies drove margin and cash flow improvements, with a 69% increase in medical course places supporting future growth. Financial leverage declined, CapEx will normalize, and PDD is expected to stabilize at 8% of net revenue.